Last reviewed · How we verify
SARS-CoV-2 virus vaccines
SARS-CoV-2 virus vaccines is a Biologic drug developed by Sheba Medical Center. It is currently in Phase 2 development.
At a glance
| Generic name | SARS-CoV-2 virus vaccines |
|---|---|
| Sponsor | Sheba Medical Center |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations (PHASE4)
- A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes (PHASE1)
- Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults (PHASE1)
- Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction (PHASE4)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals (PHASE2, PHASE3)
- Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
- Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SARS-CoV-2 virus vaccines CI brief — competitive landscape report
- SARS-CoV-2 virus vaccines updates RSS · CI watch RSS
- Sheba Medical Center portfolio CI
Frequently asked questions about SARS-CoV-2 virus vaccines
What is SARS-CoV-2 virus vaccines?
SARS-CoV-2 virus vaccines is a Biologic drug developed by Sheba Medical Center.
Who makes SARS-CoV-2 virus vaccines?
SARS-CoV-2 virus vaccines is developed by Sheba Medical Center (see full Sheba Medical Center pipeline at /company/sheba-medical-center).
What development phase is SARS-CoV-2 virus vaccines in?
SARS-CoV-2 virus vaccines is in Phase 2.
Related
- Manufacturer: Sheba Medical Center — full pipeline
- Compare: SARS-CoV-2 virus vaccines vs similar drugs
- Pricing: SARS-CoV-2 virus vaccines cost, discount & access